Ann: Capital Raising of A$3 Million-CM8.AX, page-20

First 20 Last

Share
Profile

Follow
Brighton3187

564 Posts.

19/08/16

11:33

Post #: 18557117
Share

Originally posted by Ildsrud ↑

I think they are in discussions with a large party about a serious partnership. I have a background in accounting and from my experience businesses aren't asked to supply their balance sheet unless there is a significant contract under consideration. More so if they are being directed towards a certain D/E ratio as this suggests may be the case.

@Kruiser if they drew out further funding from the convertible note that would further skew the D/E ratio, so it wouldn't have helped them if that was of primary concern. For this reason I don't think it was a need for the cash per se, it was to deleverage the balance sheet to appease the requirements of a third party.

I think something big is brewing in the background, potentially breaking new ground for Crowd. I could be totally wrong, but I am somewhat optimistic about this.

Some of the comments thrown around here towards Dom as to his character have been incredibly disrespectful. While I think it's fine to have an objective opinion of someone based on the facts, I can only hope that some of the posters here don't actually sling such poisonous comments at people they deal with in the real world as has been done on this forum. Shameful behavior in my opinion.

Expand

The most meaningful post so far for the day !!!!!!! Good analysis and interpret of the CR !thanks for the post , and I would bet my chips on your opinions which is one significant deal is underway!

CM8 Price at posting: 16.0¢ Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 85 more messages in this thread...

First 20 Last

Add UNT (ASX) to my watchlist

(20min delay)
Last 1.6¢		Change -0.001(5.88%)		Mkt cap ! $19.65M

Open	High	Low	Value	Volume
1.7¢	1.7¢	1.6¢	$72.84K	4.540M

Buyers (Bids)

No.	Vol.	Price($)
3	441703	1.6¢

Sellers (Offers)

Price($)	Vol.	No.
1.7¢	59562	1

View Market Depth

No.	Vol.	Price($)
3	441703	0.016
12	2252000	0.015
5	2251225	0.014
6	1105389	0.013
3	1400000	0.012

Price($)	Vol.	No.
0.017	59562	1
0.018	620000	2
0.019	1345000	4
0.020	1138888	5
0.021	1804688	8

Last trade - 16.10pm 07/10/2024 (20 minute delay)

UNT (ASX) Chart

Ann: Capital Raising of A$3 Million-CM8.AX, page-20

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Capital Raising of A$3 Million-CM8.AX, page-20

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News